Aykut Demirkıran

4PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 27, 2026
Prognostic Impact of the Systemic Immune-Inflammation Index According to Concurrent Chemotherapy Backbone in Stage III Non-Small Cell Lung Cancer.

|Aug 28, 2024
Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy.

Murat Araz, Ismail Beypinar, Fatih Inci

|Mar 13, 2024
The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line.

Mustafa Korkmaz, Melek Karakurt Eryılmaz, Mehmet Zahid Koçak

|Sep 22, 2023
Is the Prognostic Nutritional Index a Prognostic Marker for the Survival of Patients with Lymph-Node Positive Stage II-III Gastric Cancer Who Receive Adjuvant Chemotherapy?

Mustafa Korkmaz, Melek Karakurt Eryılmaz, Muhammed Muhiddin Er

Pageof 1

Frequent Collaborators

3 joint publications

Murat Araz

3 joint publications

Mehmet Zahid Kocak

3 joint publications

Mustafa Korkmaz

3 joint publications

Melek Karakurt Eryılmaz